Aprea Therapeutics, Inc. Financial Ratios — APRE Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-53.04	-58.51	-299.83	-67.08	-71.47	-79.37
Return on Assets (%)	- -	-34.21	-28.11	-47.24	-49.63	-259.05	-54.11	-55.58	-63.14
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-53.04	-58.51	-299.83	-67.08	-71.47	-79.37

Credit (USD)

Credit Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	1	- -	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	-0.02	-0.01	-0.01	- -	- -	- -	- -
Net Debt/EBITDA	1.54	3.98	4.43	1.69	1.43	0.77	1.4	1.6	1.1
Total Debt/EBIT	- -	- -	-0.02	-0.01	-0.01	- -	- -	- -	- -
Net Debt/EBIT	1.54	3.98	4.4	1.69	1.42	0.77	1.4	1.6	1.1
EBITDA to Interest Expense	-1,056,296.2	-90,555.42	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-1,056,296.2	-90,575.76	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-1,056,825	-90,601.12	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-144.44	-77.91	92.99	83.4	87.12	85.04	74.85	80.52	78.09
Long-Term Debt/Equity (%)	- -	- -	0.24	0.1	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	0.24	0.1	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	0.23	0.08	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	0.44	0.43	0.38	- -	- -	- -	- -
Total Debt/Capital (%)	- -	- -	0.44	0.43	0.38	- -	- -	- -	- -
Total Debt/Total Assets (%)	- -	- -	0.41	0.36	0.34	- -	- -	- -	- -
Net Debt to Equity	68.23	127.68	-104.7	-115.02	-107.21	-112.26	-127.45	-118.35	-117.34
Net Debt/Capital (%)	40.56	56.08	2,454.33	788.65	1,570.94	915.91	464.33	645.03	676.63
EBITDA	-16	-16	-29	-53	-37	-37	-15	-14	-13
EBITDA-CapEx	-16	-16	-29	-53	-37	-37	-16	-14	-13
Operating Income (Loss)	-16	-16	-30	-53	-37	-37	-15	-14	-13

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	5.67	13.49	14.36	5.81	7.25	8.99	4.93	6.8	5.28
Current Ratio	5.75	13.56	14.68	6.03	7.73	9.42	5.14	7.01	5.63
Quick Ratio	5.67	13.49	14.36	5.81	7.25	8.99	4.93	6.8	5.28
CFO/Avg Current Liab	- -	-3.33	-3.83	-3.43	-3.33	-4.76	-3.21	-3.5	-4.21
Common Equity/Total Assets	-144.44	-77.91	92.99	83.4	87.12	85.04	74.85	80.52	78.09
Long-Term Debt/Equity (%)	- -	- -	0.24	0.1	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	0.24	0.1	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	0.23	0.08	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	0.44	0.43	0.38	- -	- -	- -	- -
Total Debt/Capital (%)	- -	- -	0.44	0.43	0.38	- -	- -	- -	- -
Total Debt/Total Assets (%)	- -	- -	0.41	0.36	0.34	- -	- -	- -	- -
CFO/Total Liabilities	-23.13	-12.98	-285.22	-271.27	-515.08	-554.31	-213.77	-290.17	-369.29
CFO/CapEx	- -	-4,119.46	-864.33	-1,625.99	- -	- -	-130.81	-875.87	- -
Altman's Z-Score	-3.78	-1.04	61.25	1.01	-0.45	-14.32	-18.49	-17.39	-29.89

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	965	104	63	18	18	18	7
- Cash & Cash Equivalents	24	66	130	89	53	29	22	23	15
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	1	- -	- -	- -	- -	- -	- -
Enterprise Value	-24	-66	835	16	10	-11	-4	-5	-8
Total Capital	-36	-51	125	78	50	26	17	19	12
Total Debt/Capital (%)	- -	- -	0.44	0.43	0.38	- -	- -	- -	- -
Total Debt / EV	- -	- -	- -	0.02	0.02	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	275	104	61	11	17	18	6
Diluted Enterprise Value	-24	-66	146	15	8	-18	-5	-5	-9
EV per Share	- -	- -	794.56	14.69	9.01	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-16	-16	-29	-53	-37	-37	-15	-14	-13
TTM Operating Income	-16	-16	-30	-53	-37	-37	-15	-14	-13
TTM Cash Flow to Firm	-14	-15	-27	-42	-38	-25	-12	-14	-13
TTM Free Cash Flow to Firm	-14	-15	-27	-42	-38	-25	-12	-14	-13

Multiples (USD)

Valuation Multiples API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-10.33	-2.49	-1.62	-0.44	-1.41	-1.34	-0.43
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-24	-66	835	16	10	-11	-4	-5	-8
Low Price	- -	- -	302	94.6	55.76	6.08	2.78	2.15	0.84
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-5.89	-11.96	-2.78	-0.34	-1.19	-1.93	-0.99
Price/Earnings High	- -	- -	-11.36	-18.18	-4.85	-0.94	-3.04	-3.76	-2.59
Price/Earnings Low	- -	- -	-3.23	-1.87	-1.6	-0.09	-0.7	-0.91	-0.44
Price/Book Value	- -	- -	7.76	1.35	1.27	0.69	1.04	0.93	0.56
Price/Book Value Average	- -	- -	4.66	8.28	2.14	2.38	1.03	1.29	1.26
Price/Book Value High	- -	- -	8.99	12.59	3.74	6.65	2.64	2.51	3.29
Price/Book Value Low	- -	- -	2.56	1.29	1.23	0.63	0.61	0.61	0.55
Price/Tangible Book Value	- -	- -	7.76	1.35	1.27	0.69	1.04	0.93	0.56
Price/Tangible Book Value Average	- -	- -	4.66	8.28	2.14	2.38	1.03	1.29	1.26
Price/Tangible Book Value High	- -	- -	8.99	12.59	3.74	6.65	2.64	2.51	3.29
Price/Tangible Book Value Low	- -	- -	2.56	1.29	1.23	0.63	0.61	0.61	0.55
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	-10.31	-2.49	-1.62	-0.44	-1.4	-1.34	-0.43
Price/Cash Flow Average	- -	- -	-6.19	-15.29	-2.74	-1.52	-1.39	-1.84	-0.97
Price/Cash Flow High	- -	- -	-11.94	-23.26	-4.78	-4.25	-3.56	-3.6	-2.54
Price/Cash Flow Low	- -	- -	-3.39	-2.39	-1.57	-0.4	-0.83	-0.87	-0.43
Price/Free Cash Flow Average	- -	- -	-6.2	-15.3	-2.74	-1.52	-1.4	-1.85	-0.97
Price/Free Cash Flow High	- -	- -	-11.95	-23.27	-4.78	-4.25	-3.59	-3.6	-2.54
Price/Free Cash Flow Low	- -	- -	-3.4	-2.39	-1.57	-0.4	-0.83	-0.87	-0.43
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	1.54	3.98	-15.3	-10.5	-1.42	-0.87	0.26	-0.14	-0.08
EV/EBITDA High	1.54	3.98	-33.6	-16.85	-3.55	-3.81	-1.5	-1.79	-2
EV/EBITDA Low	1.54	3.98	-6.4	-0.22	-0.22	0.34	0.73	0.77	0.58
EV/EBIT Average	1.54	3.98	-15.21	-10.46	-1.41	-0.86	0.26	-0.14	-0.08
EV/EBIT High	1.54	3.98	-33.41	-16.78	-3.53	-3.79	-1.5	-1.79	-1.99
EV/EBIT Low	1.54	3.98	-6.36	-0.22	-0.22	0.34	0.73	0.77	0.58
Last Price	- -	- -	917.8	98.4	57.4	6.62	4.7	3.29	0.85
High Price	- -	- -	1,062.2	920	169.2	64.2	12	8.85	5
Enterprise Value Average	-24	-66	449	552	53	32	-4	2	1
Enterprise Value High	-24	-66	987	886	132	142	23	26	26
Enterprise Value Low	-24	-66	188	12	8	-13	-11	-11	-8

Shares Outstanding	1	1	1	1	1	3	4	5	8
Diluted Weighted Avg Shares	1	1	- -	1	1	2	4	6	7
Basic Weighted Avg Shares	1	1	- -	1	1	2	4	6	7
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-22.51	-23.42	-97.87	-49.76	-34.93	-22.44	-4.27	-2.59	-2.02
Operating Income per Share	-22.52	-23.43	-98.44	-49.98	-35.18	-22.55	-4.28	-2.6	-2.02
Basic EPS, GAAP	-21.58	-22.06	-93.49	-50.61	-34.88	-67.99	-3.95	-2.35	-1.93
Basic EPS from Cont Ops	-21.58	-22.06	-93.49	-50.61	-34.88	-67.99	-3.95	-2.35	-1.93
Diluted EPS, GAAP	-21.58	-22.06	-93.49	-50.61	-34.88	-67.99	-3.95	-2.35	-1.93
Diluted EPS from Cont Ops	-21.58	-22.06	-93.49	-50.61	-34.88	-67.99	-3.95	-2.35	-1.93
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-19.9	-21.67	-88.99	-39.56	-35.41	-15.09	-3.37	-2.46	-1.97
Free Cash Flow per Basic Share	-19.9	-21.67	-89.1	-39.58	-35.41	-15.09	-3.39	-2.46	-1.97
Cash & Equivalents per Share	25.41	68.38	123.76	84.03	48.56	10.84	5.78	4.17	1.78
Book Value per Share	-37.24	-53.55	118.2	73.06	45.3	9.66	4.54	3.52	1.52
Tangible Book Value per Share	-37.24	-53.55	118.2	73.06	45.3	9.66	4.54	3.52	1.52

Aprea Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)